Hot Features
Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Kyverna Therapeutics is a cell therapy company engineering a new class of therapies for autoimmune and inflammatory diseases. The Kyverna therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin... Kyverna Therapeutics is a cell therapy company engineering a new class of therapies for autoimmune and inflammatory diseases. The Kyverna therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the origin of autoimmune and inflammatory diseases. Kyverna's pipeline includes next-generation chimeric antigen receptor T-cell (CAR T) therapies in both autologous and allogeneic formats with properties well suited for use in B cell-driven autoimmune diseases. Mehr anzeigen
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0249 | 0.941398865785 | 2.645 | 2.68 | 2.43 | 224607 | 2.56227905 | CS |
| 4 | 0.0099 | 0.372180451128 | 2.66 | 3.2397 | 2.43 | 269211 | 2.78720182 | CS |
| 12 | -1.0951 | -29.0863213811 | 3.765 | 4.26 | 2.43 | 354828 | 3.3134744 | CS |
| 26 | -4.3701 | -62.0752840909 | 7.04 | 7.35 | 2.43 | 357941 | 4.39578017 | CS |
| 52 | -26.1301 | -90.7295138889 | 28.8 | 30.6 | 2.43 | 438055 | 9.30943764 | CS |
| 156 | -31.5801 | -92.2046715328 | 34.25 | 35.01 | 2.43 | 437567 | 10.95492057 | CS |
| 260 | -31.5801 | -92.2046715328 | 34.25 | 35.01 | 2.43 | 437567 | 10.95492057 | CS |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
